A federal judge let a doctor’s free-speech and due-process lawsuit against Maine’s medical board move ahead, challenging how the state punished her COVID-19 views and prescriptions.
Story Snapshot
- A judge allowed Dr. Meryl Nass’s lawsuit against Maine’s medical board to proceed.
- The board had suspended her license and ordered a psychological evaluation in 2022.
- The case tests the line between protected speech and medical discipline during COVID-19.
- A state court later voided the psychological evaluation order as arbitrary.
What The Federal Court Just Decided
Chief United States District Judge Lance E. Walker ruled that Dr. Meryl Nass’s case against the Maine Board of Licensure in Medicine can continue. The suit claims the board targeted her for public statements about COVID-19 and for prescribing ivermectin and hydroxychloroquine to some patients. The board’s actions, she argues, violated her First Amendment rights and due process. The case now moves into discovery and arguments on the merits, instead of ending at the motion-to-dismiss stage.
Judge Walker’s order follows years of back-and-forth. In January 2022, the board first suspended Nass’s license on an emergency basis. It said preliminary findings showed fraud, deceit, or misrepresentation, and a risk to public safety. The board also directed her to a neuropsychological evaluation by a board-picked doctor. The board cited complaints tied to her COVID-19 views and prescriptions as the trigger for these steps.
How The Board Justified Discipline
The board has publicly said it acted because Nass’s statements about COVID-19 and the federal response were inconsistent with its policy against spreading vaccine misinformation. It has also said Nass engaged in incompetence, unprofessional conduct, and misrepresentation during patient care. In public reporting, Nass acknowledged once giving a pharmacist a false diagnosis to secure hydroxychloroquine, which the board treated as misrepresentation. These items formed part of the board’s rationale for discipline.
Regulators across the country took similar stands during the pandemic. Many warned that doctors must follow the standard of care when advising on COVID-19. At the same time, scholars and courts have cautioned boards not to punish protected speech, especially outside the exam room. That tension sits at the heart of Nass’s case: whether a state board can police a doctor’s public views while staying within constitutional limits.
Why The Ruling Matters Beyond One Doctor
The federal judge’s decision does not decide who is right. It does say the claims deserve a full hearing. That is notable because a Maine state court already struck down the order forcing Nass to undergo a psychological evaluation, calling the order arbitrary and unsupported. Together, these moves suggest courts are willing to check boards when their processes are weak or their orders reach too far.
The stakes go beyond COVID-19. Off-label prescribing is common and legal. Federal law allows doctors to use approved drugs for new purposes when they judge it may help a patient. During the pandemic, boards treated some off-label COVID-19 uses as substandard. Courts are now sorting out where clinical judgment ends and discipline begins, and how speech rules apply when doctors speak in public about health policy.
What It Signals About Trust And Power
Many Americans on both the right and left worry that gatekeepers use rules to protect their own power. This case taps that concern. A state board used emergency powers, a public “misinformation” policy, and a forced exam order to shut down a dissenting doctor. A judge then said, not so fast. That back-and-forth highlights a core test for institutions: can they enforce safety and standards without silencing debate or skipping due process?
📷Judge Rules for Doctor Who Prescribed Ivermectin for COVID-19
A doctor’s lawsuit against Maine’s medical board can proceed, a federal judge has ruled. An order from the Maine Board of Licensure in Medicine that Dr. Meryl Nass undergo a… pic.twitter.com/YKXgyAj8iI— joe t (@jtinaglia) August 25, 2026
For patients and doctors, the message is mixed. Regulators still expect care that meets accepted standards. Courts still protect speech and fair process. The lesson is to keep records clear, inform patients fully, and ground care in evidence. The legal lesson for boards is just as clear: write precise rules, tie orders to solid facts, and separate public speech from provable bedside harm. That balance is how trust is built after a hard era.
Sources:
medpagetoday.com, mainepublic.org, govinfo.gov, justthenews.com, thehill.com, news.vaquill.com, centerforinquiry.s3.amazonaws.com, quackwatch.org, childrenshealthdefense.org
© unitedfrontnews.com 2026. All rights reserved.
